Alembic Pharmaceuticals Limited Fenofibrate Export Data — India (DGFT 2022–2026)

Name: Alembic Pharmaceuticals Limited Fenofibrate Export Records India — #11 Exporter, 129 Shipments, $1.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Fenofibrate

India Pharmaceutical Trade Intelligence

$73.4M168 Suppliers81 CountriesHS 30049099

ExportsIndia → UNITED STATES43.4%India → BELGIUM8.7%

ImportsUNITED STATES → India$13.3K CANADA → India$3.1K

#1 Buyer: YUSEN LOGISTICS

Alembic Pharmaceuticals Limited — Fenofibrate Exporter #11 | $1.5M Trade Value | TransData Nexus | TransData Nexus

Alembic Pharmaceuticals Limited — Fenofibrate Exporter Profile

Indian Pharmaceutical Exporter · #11 for Fenofibrate · $1.5M export value · DGFT Verified

Alembic Pharmaceuticals Limited is the #11 Indian exporter of Fenofibrate with $1.5M in export value and 129 verified shipments. Alembic Pharmaceuticals Limited holds a 2.0% market share in Fenofibrate exports across 1 countries. The company exports 37 pharmaceutical products worth $127.6M across 16 therapeutic categories.

Alembic Pharmaceuticals Limited — Fenofibrate Export Profile: Buyers & Destinations

Alembic Pharmaceuticals Limited Fenofibrate export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Fenofibrate?

Country	Value	Shipments	Share
UNITED STATES	$31.8M	1,315	58.3%
BELGIUM	$6.4M	176	11.7%
AUSTRALIA	$4.3M	85	7.8%
PHILIPPINES	$3.1M	129

Who Are the Top Buyers of Fenofibrate from India?

Buyer	Country	Value	Orders
LIFESTAR PHARMA LLC	UNITED STATES	$4.7M	293
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$3.7M	74
CIPLA USA INC UPS SUPPLY CHAIN SOLU	UNITED STATES	$3.2M	234
AMNEAL PHARMACEUTICALS, LLC (KY)	UNITED STATES	$2.4M	47
MYLAN PHARMACEUTICALS INC,	UNITED STATES	$1.7M	37
MYLAN HUNGARY KFT	FRANCE	$1.3M	25
MYLAN LABORATORIES SAS	FRANCE	$950.0K	19
DIRECT CUSTOMER SOLUTIONS LLC	UNITED STATES	$800.0K	16
ARROW PHARMACEUTICALS PTY LTD,	AUSTRALIA	$700.0K	14
AJANTA PHARMA PHILIPPINES INC	PHILIPPINES	$500.0K	10

India's Fenofibrate is purchased by 368 buyers worldwide. The top buyer is LIFESTAR PHARMA LLC (UNITED STATES), followed by YUSEN LOGISTICS BENELUX BELGIUM and CIPLA USA INC UPS SUPPLY CHAIN SOLU.

How Does Alembic Pharmaceuticals Limited Compare to Nearest Fenofibrate Exporters?

Exporters ranked immediately above and below #11 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
9	AMNEAL PHARMACEUTICALS PRIVATE LIMITED	$3.1M	62	1	$50.0K
1	ABBOTT HEALTHCARE PRIVATE LIMITED	$2.5M	50	5	$50.0K
11	ALEMBIC PHARMACEUTICALS LIMITED ★	$1.5M	129	1	$11.6K
12	INVENTIA HEALTHCARE LIMITED	$1.4M	60	4	$24.0K
14	TORRENT PHARMACEUTICALS LTD	$1.4M	41	5	$34.6K

Alembic Pharmaceuticals Limited ranks #11 among 168 Indian Fenofibrate exporters. Average shipment value of $11.6K compared to the market average of $286.5K. The closest competitors by value are AMNEAL PHARMACEUTICALS PRIVATE LIMITED and ABBOTT HEALTHCARE PRIVATE LIMITED.

Which Indian Ports Ship Fenofibrate Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	361	12.9%
SAHAR AIR	281	10.1%
SAHAR AIR CARGO ACC (INBOM4)	229	8.2%
DELHI AIR CARGO ACC (INDEL4)	227	8.1%
JNPT/ NHAVA SHEVA SEA	203	7.3%
DELHI AIR	143	5.1%
HYDERABAD ICD	125	4.5%
JNPT	115	4.1%

Geopolitical & Trade Policy Impact on Alembic Pharmaceuticals Limited's Fenofibrate Exports

Alembic's export operations are intricately linked to global trade routes, making them susceptible to geopolitical tensions. The recent escalation of conflicts in the Middle East, particularly the Israel-Iran tensions, has led to heightened security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor. Major carriers have altered their routes, opting for the longer passage around the Cape of Good Hope, resulting in extended transit times by 10–20 days and increased freight rates by 40–50% on key India–Europe routes. (livemint.com) For Alembic, which exports to European markets, these disruptions could lead to delays and elevated shipping costs, impacting supply chain efficiency and profitability.

Conversely, the ongoing U.S.-China trade tensions have created opportunities for Indian pharmaceutical exporters. The United States' efforts to diversify its supply chain away from China have opened avenues for companies like Alembic to strengthen their presence in the U.S. market. The company's proactive approach is evident in its acquisition of Utility Therapeutics Ltd., facilitating entry into the U.S. branded drug segment. (pharma.economictimes.indiatimes.com) However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for Alembic's operations in Europe. Ensuring adherence to serialization and traceability requirements is essential to maintain market access and avoid regulatory penalties.

Alembic Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Alembic Pharmaceuticals has consistently demonstrated adherence to stringent regulatory standards set by agencies such as the USFDA, WHO, and EU GMP. The company's manufacturing facilities have received approvals from various international regulatory bodies, underscoring its commitment to quality and compliance. (en.wikipedia.org) Notably, Alembic's proactive approach to addressing regulatory challenges is evident in its successful resolution of the nitrosamine issue affecting products like Duloxetine. By stabilizing the product and obtaining necessary dossier approvals, the company has reinforced its dedication to product safety and regulatory compliance. (alembiclimited.com)

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Fenofibrate shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Alembic Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 81+ countries, 368+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Fenofibrate

Fenofibrate

Alembic Pharmaceuticals Limited — Fenofibrate Exporter Profile

Alembic Pharmaceuticals Limited — Fenofibrate Export Profile: Buyers & Destinations

Where Does India Export Fenofibrate?

Who Are the Top Buyers of Fenofibrate from India?

What Is India's Total Fenofibrate Export Value and How Much Does Alembic Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Alembic Pharmaceuticals Limited's Fenofibrate Exports?

How Does Alembic Pharmaceuticals Limited Compare to Other Indian Fenofibrate Exporters?

Regulatory Requirements: Exporting Fenofibrate to Key Markets

United States — FDA

Australia — TGA

How Does Alembic Pharmaceuticals Limited Compare to Nearest Fenofibrate Exporters?

Which Indian Ports Ship Fenofibrate Exports?

What Other Lipid & Metabolism Products Does Alembic Pharmaceuticals Limited Export?

Geopolitical & Trade Policy Impact on Alembic Pharmaceuticals Limited's Fenofibrate Exports

Alembic Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Alembic Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Fenofibrate Export Data from Alembic Pharmaceuticals Limited

Fenofibrate Stats

Company Overview

Top Products by Alembic Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source